Works matching IS 01145916 AND DT 2024 AND VI 47 AND IP 11

Results: 8

Acute Appendicitis After COVID-19 Vaccines in Italy: A Self-Controlled Case Series Study.

Published in:

Drug Safety, 2024, v. 47, n. 11, p. 1157, doi. 10.1007/s40264-024-01462-0

By:

Morciano, Cristina;
Massari, Marco;
Cutillo, Maria;
Belleudi, Valeria;
Trifirò, Gianluca;
Mores, Nadia;
Sapigni, Ester;
Puccini, Aurora;
Zanoni, Giovanna;
Zorzi, Manuel;
Monaco, Giuseppe;
Leoni, Olivia;
Del Zotto, Stefania;
Samez, Sarah;
Mayer, Flavia;
Marano, Giuseppe;
Menniti Ippolito, Francesca;
Da Cas, Roberto;
Traversa, Giuseppe;
Spila Alegiani, Stefania

Publication type:

Article

The Methodological Quality of Observational Studies Examining the Risk of Pregnancy Drug Use on Congenital Malformations Needs Substantial Improvement: A Cross-Sectional Survey.

Published in:

Drug Safety, 2024, v. 47, n. 11, p. 1171, doi. 10.1007/s40264-024-01465-x

By:

Jia, Yulong;
Wang, Jing;
Liu, Chunrong;
Zhao, Peng;
Ren, Yan;
Xiong, Yiquan;
Li, GuoWei;
Chen, Meng;
Sun, Xin;
Tan, Jing

Publication type:

Article

A Systematic Overview of Contraindications and Special Warnings for Biologic and Targeted Synthetic Disease Modifying Antirheumatic Drugs: Establishing a Framework to Create a "Safety Checklist".

Published in:

Drug Safety, 2024, v. 47, n. 11, p. 1075, doi. 10.1007/s40264-024-01461-1

By:

Skaarup, Lykke;
Ingrid, Elvina;
Sepriano, Alexandre;
Nikiphorou, Elena;
Østgård, René;
Lauper, Kim;
Grosse-Michaelis, Ilona;
Kloppenburg, Margreet;
Glintborg, Bente;
Liew, David F. L.;
Kragstrup, Tue W.

Publication type:

Article

Optimal Significance Levels and Sample Sizes for Signal Detection Methods Based on Non-constant Hazards.

Published in:

Drug Safety, 2024, v. 47, n. 11, p. 1149, doi. 10.1007/s40264-024-01460-2

By:

Sauzet, Odile;
Dyck, Julia;
Cornelius, Victoria

Publication type:

Article

Enhanced Safety Surveillance of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany, and Spain During the 2022/2023 Influenza Season.

Published in:

Drug Safety, 2024, v. 47, n. 11, p. 1137, doi. 10.1007/s40264-024-01456-y

By:

de la Cueva, Ignacio Salamanca;
Gerber, Jennifer E.;
Hastie, Andrew;
Brotons, Carlos;
Panzer, Falko;
Pirçon, Jean-Yves;
Talsma, Paul;
Eckermann, Tamara;
Nikic, Vanja;
Gomez, Xavier Martinez;
Alsdurf, Hannah

Publication type:

Article

Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals.

Published in:

Drug Safety, 2024, v. 47, n. 11, p. 1061, doi. 10.1007/s40264-024-01453-1

By:

Lunghi, Carlotta;
Domenicali, Marco;
Vertullo, Stefano;
Raschi, Emanuel;
De Ponti, Fabrizio;
Onder, Graziano;
Poluzzi, Elisabetta

Publication type:

Article

Identification of Pregnancy Adverse Drug Reactions in Pharmacovigilance Reporting Systems: A Novel Algorithm Developed in EudraVigilance.

Published in:

Drug Safety, 2024, v. 47, n. 11, p. 1127, doi. 10.1007/s40264-024-01448-y

By:

Zaccaria, Cosimo;
Piccolo, Loris;
Gordillo-Marañón, María;
Touraille, Gilles;
de Vries, Corinne

Publication type:

Article

Tardive Dyskinesia with Antipsychotic Medication in Children and Adolescents: A Systematic Literature Review.

Published in:

Drug Safety, 2024, v. 47, n. 11, p. 1095, doi. 10.1007/s40264-024-01446-0

By:

Besag, Frank M. C.;
Vasey, Michael J.;
Salim, Iffah;
Hollis, Chris

Publication type:

Article